{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:05Z","timestamp":1791928925378,"version":"4.3.4"},"reference-count":71,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"13","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,10,28]]},"DOI":"10.1167\/iovs.66.13.45","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:32:56Z","timestamp":1761661976000},"page":"45","source":"Crossref","is-referenced-by-count":3,"title":["Dualistic Role of MITF in Uveal Melanoma: Defining Two Distinct Cellular Subpopulations With Prognostic and Therapeutic Implications"],"prefix":"10.1167","volume":"66","author":[{"given":"Justyna","family":"Pilch","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Pathology, Wroclaw Medical University, Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Krzyzi\u0144ski","sequence":"additional","affiliation":[{"name":"Faculty of Mathematics and Information Science, Warsaw University of Technology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Markiewicz","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College, Faculty of Medicine, Department of Ophthalmology and Ocular Oncology, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemyslaw","family":"Biecek","sequence":"additional","affiliation":[{"name":"Faculty of Mathematics and Information Science, Warsaw University of Technology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina J.","family":"Mazur","sequence":"additional","affiliation":[{"name":"Department of Cell Pathology, Faculty of Biotechnology, University of Wroclaw, Poland, Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u017cena","family":"Romanowska-Dixon","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College, Faculty of Medicine, Department of Ophthalmology and Ocular Oncology, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai P.","family":"Hoang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Donizy","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Pathology, Wroclaw Medical University, Wroclaw, Poland"},{"name":"Department of Pathology and Clinical Cytology, Jan Mikulicz-Radecki University Hospital, Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"100800","DOI":"10.1016\/j.preteyeres.2019.100800","article-title":"Uveal melanoma: Towards a molecular understanding","volume":"75","author":"Smit","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/cncr.29727","article-title":"Uveal melanoma: From diagnosis to treatment and the science in between","volume":"122","author":"Chattopadhyay","year":"2016","journal-title":"Cancer"},{"issue":"1","key":"bib3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"bib4","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.3390\/ijms23116001","article-title":"MITF in normal melanocytes, cutaneous and uveal melanoma: a delicate balance","volume":"23","author":"Gelmi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/0092-8674(93)90429-T","article-title":"Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein","volume":"74","author":"Hodgkinson","year":"1993","journal-title":"Cell"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/BF01977676","article-title":"A DNA insertional mutation results in microphthalmia in transgenic mice","volume":"2","author":"Krakowsky","year":"1993","journal-title":"Transgenic Res"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.drudis.2016.09.016","article-title":"Downregulation of melanogenesis: drug discovery and therapeutic options","volume":"22","author":"Pillaiyar","year":"2017","journal-title":"Drug Discov Today"},{"issue":"10","key":"bib8","doi-asserted-by":"publisher","first-page":"8861","DOI":"10.3390\/ijms24108861","article-title":"Microphthalmia-associated transcription factor: a differentiation marker in uveal melanoma","volume":"24","author":"Gelmi","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"19","key":"bib9","doi-asserted-by":"publisher","first-page":"e2107006119","DOI":"10.1073\/pnas.2107006119","article-title":"MITF deficiency accelerates GNAQ-driven uveal melanoma","volume":"119","author":"Phelps","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/pcmr.13057","article-title":"MITF deficiency and oncogenic GNAQ each promote proliferation programs in zebrafish melanocyte lineage cells","volume":"35","author":"Phelps","year":"2022","journal-title":"Pigment Cell Melanoma Res"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/archopht.120.4.466","article-title":"Immunophenotypic differences between uveal and cutaneous melanomas","volume":"120","author":"Iwamoto","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0014-4835(03)00082-4","article-title":"Microphthalmia transcription factor analysis in posterior uveal melanomas","volume":"76","author":"Mouriaux","year":"2003","journal-title":"Exp Eye Res"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1038\/onc.2010.598","article-title":"Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny","volume":"30","author":"Cheli","year":"2011","journal-title":"Oncogene"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/j.1755-148X.2010.00757.x","article-title":"Cancer stem cells versus phenotype-switching in melanoma","volume":"23","author":"Hoek","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.3390\/cells13161348","article-title":"Co-targeting of DTYMK and PARP1 as a potential therapeutic approach in uveal melanoma","volume":"13","author":"Ozieblo","year":"2024","journal-title":"Cells"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41388-023-02887-0","article-title":"PRAME induces genomic instability in uveal melanoma","volume":"43","author":"Kurtenbach","year":"2024","journal-title":"Oncogene"},{"issue":"15","key":"bib17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1167\/iovs.64.15.36","article-title":"PRAME expression: a target for cancer immunotherapy and a prognostic factor in uveal melanoma","volume":"64","author":"Gelmi","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12964-023-01197-y","article-title":"Intrinsic disorder in PRAME and its role in uveal melanoma","volume":"21","author":"Antonietti","year":"2023","journal-title":"Cell Commun Signal"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41418-020-00709-4","article-title":"Roles and mechanisms of BAP1 deubiquitinase in tumor suppression","volume":"28","author":"Masclef","year":"2021","journal-title":"Cell Death Differ"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejca.2022.07.031","article-title":"Machine learning models demonstrate that clinicopathologic variables are comparable to gene expression prognostic signature in predicting survival in uveal melanoma","volume":"174","author":"Donizy","year":"2022","journal-title":"Eur J Cancer"},{"issue":"2","key":"bib21","doi-asserted-by":"publisher","first-page":"100398","DOI":"10.1016\/j.modpat.2023.100398","article-title":"Deep learning-based H-score quantification of immunohistochemistry-stained images","volume":"37","author":"Wen","year":"2024","journal-title":"Mod Pathol"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.3390\/ijms25084335","article-title":"H-VISTA immunohistochemistry score is associated with advanced stages in cutaneous and ocular melanoma","volume":"25","author":"Tinca","year":"2024","journal-title":"Int J Mol Sci"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0167-9473(98)00096-6","article-title":"An application of changepoint methods in studying the effect of age on survival in breast cancer","volume":"30","author":"Contal","year":"1999","journal-title":"Comput Stat Data Anal"},{"issue":"6","key":"bib24","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1371\/journal.pmed.0050120","article-title":"Improving melanoma classification by integrating genetic and morphologic features","volume":"5","author":"Viros","year":"2008","journal-title":"PLoS Med"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/pcmr.12370","article-title":"Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy","volume":"28","author":"Wellbrock","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"bib27","doi-asserted-by":"crossref","first-page":"5436988","DOI":"10.1155\/2022\/5436988","article-title":"EMT-related gene signature predicts the prognosis in uveal melanoma patients","volume":"2022","author":"Lv","year":"2022","journal-title":"J Oncol"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and cancer","volume":"13","author":"Carbone","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s12276-023-00979-1","article-title":"BAP1 as a guardian of genome stability: implications in human cancer","volume":"55","author":"Kwon","year":"2023","journal-title":"Exp Mol Med"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","article-title":"Biological mechanisms and clinical significance of BAP1 mutations in human cancer","volume":"10","author":"Carbone","year":"2020","journal-title":"Cancer Discov"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3390\/cancers13051143","article-title":"Intratumor heterogeneity in uveal melanoma BAP-1 expression","volume":"13","author":"St\u00e5lhammar","year":"2021","journal-title":"Cancers"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1158\/0008-5472.CAN-20-3430","article-title":"Roles of the BAP1 tumor suppressor in cell metabolism","volume":"81","author":"Han","year":"2021","journal-title":"Cancer Res"},{"issue":"1","key":"bib33","doi-asserted-by":"publisher","first-page":"8923","DOI":"10.1038\/s41598-021-88390-6","article-title":"Estimation of the timing of BAP1 mutation in uveal melanoma progression","volume":"11","author":"Uner","year":"2021","journal-title":"Sci Rep"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41388-020-01554-y","article-title":"BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors","volume":"40","author":"Han","year":"2021","journal-title":"Oncogene"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ccr.2004.10.014","article-title":"Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF","volume":"6","author":"Du","year":"2004","journal-title":"Cancer Cell"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1101\/gad.406406","article-title":"Mitf regulation of Dia1 controls melanoma proliferation and invasiveness","volume":"20","author":"Carreira","year":"2006","journal-title":"Genes Dev"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.phrs.2015.04.006","article-title":"The MITF family of transcription factors: role in endolysosomal biogenesis, Wnt signaling, and oncogenesis","volume":"99","author":"Ploper","year":"2015","journal-title":"Pharmacol Res"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0092-8674(02)00762-6","article-title":"Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability","volume":"109","author":"McGill","year":"2002","journal-title":"Cell"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/jid.2008.255","article-title":"MiTF regulates cellular response to reactive oxygen species through transcriptional regulation of APE-1\/Ref-1","volume":"129","author":"Liu","year":"2009","journal-title":"J Invest Dermatol"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1200\/JCO.24.00447","article-title":"15-gene expression profile and PRAME as integrated prognostic test for uveal melanoma: first report of collaborative ocular oncology group study no. 2 (COOG2.1)","volume":"42","author":"Harbour","year":"2024","journal-title":"J Clin Oncol"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1097\/IAE.0000000000004153","article-title":"Comprehensive molecular profiling of uveal melanoma evaluated with gene expression profiling, preferentially expressed antigen in melanoma expression, and next-generation sequencing","volume":"44","author":"Alsoudi","year":"2024","journal-title":"Retina"},{"issue":"111434","key":"bib42","doi-asserted-by":"crossref","first-page":"111434","DOI":"10.1016\/j.cellsig.2024.111434","article-title":"A comprehensive review of PRAME and BAP1 in melanoma: Genomic instability and immunotherapy targets","volume":"124","author":"Aljabali","year":"2024","journal-title":"Cell Signal"},{"issue":"8","key":"bib43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12032-023-02086-7","article-title":"The evolving landscape of involvement of DTYMK enzymes in cancer","volume":"40","author":"Heydari","year":"2023","journal-title":"Med Oncol"},{"issue":"6","key":"bib44","doi-asserted-by":"publisher","first-page":"e1003531","DOI":"10.1371\/journal.pgen.1003531","article-title":"PARP-1 regulates metastatic melanoma through modulation of vimentin-induced malignant transformation","volume":"9","author":"Rodr\u00edguez","year":"2013","journal-title":"PLoS Genet"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/ng.3927","article-title":"A common intronic variant of PARP1 confers melanoma risk and mediates melanocyte growth via regulation of MITF","volume":"49","author":"Choi","year":"2017","journal-title":"Nat Genet"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.21037\/jgo-23-393","article-title":"Deoxythymidylate kinase (DTYMK) participates in cell cycle arrest to promote pancreatic adenocarcinoma progression regulated by miR-491-5p through TP53 and is associated with tumor immune infiltration","volume":"14","author":"Bao","year":"2023","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"bib47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13205-021-03038-6","article-title":"Pleiotropic role of PARP1: an overview","volume":"12","author":"Kumar","year":"2022","journal-title":"3 Biotech"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1158\/1078-0432.CCR-15-2071","article-title":"PRAME as an independent biomarker for metastasis in uveal melanoma","volume":"22","author":"Field","year":"2016","journal-title":"Clin Cancer Res"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41388-023-02887-0","article-title":"PRAME induces genomic instability in uveal melanoma","volume":"43","author":"Kurtenbach","year":"2024","journal-title":"Oncogene"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/cells10020285","article-title":"The prognostic values of PARP-1 expression in uveal melanoma","volume":"10","author":"Gajdzis","year":"2021","journal-title":"Cells"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1755-148X.2009.00653.x","article-title":"Fifteen-year quest for microphthalmia-associated transcription factor target genes","volume":"23","author":"Cheli","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1136\/bjo-2023-323181","article-title":"Prognostic significance of melanogenesis pathway and its association with the ultrastructural characterisation of melanosomes in uveal melanoma","volume":"109","author":"Jha","year":"2025","journal-title":"Br J Ophthalmol"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"112651","DOI":"10.1016\/j.biopha.2022.112651","article-title":"Decursin prevents melanogenesis by suppressing MITF expression through the regulation of PKA\/CREB, MAPKs, and PI3K\/Akt\/GSK-3\u00df cascades","volume":"147","author":"Choi","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/pcmr.12611","article-title":"Beyond MITF: Multiple transcription factors directly regulate the cellular phenotype in melanocytes and melanoma","volume":"30","author":"Seberg","year":"2017","journal-title":"Pigment Cell Melanoma Res"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1167\/iovs.65.1.42","article-title":"Tumor pigmentation does not affect light-activated belzupacap sarotalocan treatment but influences macrophage polarization in a murine melanoma model","volume":"65","author":"Ma","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"bib57","doi-asserted-by":"publisher","first-page":"100297","DOI":"10.1016\/j.xops.2023.100297","article-title":"Increased histological tumor pigmentation in uveal melanoma is related to eye color and loss of chromosome 3\/BAP1","volume":"3","author":"Gelmi","year":"2023","journal-title":"Ophthalmol Sci"},{"issue":"1","key":"bib58","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13244-021-01000-x","article-title":"Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging-Part I: MR imaging with pathologic correlation and technical considerations","volume":"12","author":"Foti","year":"2021","journal-title":"Insights Imaging"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3390\/diagnostics14090958","article-title":"Pathological and molecular diagnosis of uveal melanoma","volume":"14","author":"Pasarica","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"924553","DOI":"10.3389\/fonc.2022.924553","article-title":"Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance","volume":"12","author":"Popovic","year":"2022","journal-title":"Front Oncol"},{"issue":"43","key":"bib61","doi-asserted-by":"publisher","first-page":"E924","DOI":"10.1073\/pnas.1106351108","article-title":"Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF","volume":"108","author":"Feige","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/pcmr.12802","article-title":"MITF controls the TCA cycle to modulate the melanoma hypoxia response","volume":"32","author":"Louphrasitthiphol","year":"2019","journal-title":"Pigment Cell Melanoma Res"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3390\/biology12050738","article-title":"Characterization and Quantitation of the Tumor Microenvironment of Uveal Melanoma","volume":"12","author":"Goesmann","year":"2023","journal-title":"Biology"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12026-022-09277-w","article-title":"Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors","volume":"70","author":"Musick","year":"2022","journal-title":"Immunol Res"},{"issue":"Suppl 1","key":"bib65","first-page":"A980","article-title":"980 Prognostic significance of M1\/M2 tumor-associated macrophages with pigmentation in uveal melanoma","volume":"11","author":"Jha","year":"2023","journal-title":"J Immunother Cancer"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J Biomed Sci"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1158\/1541-7786.MCR-21-0657","article-title":"Multi-omics profiling shows BAP1 loss is associated with upregulated cell adhesion molecules in uveal melanoma","volume":"20","author":"Baqai","year":"2022","journal-title":"Mol Cancer Res"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/s12967-022-03813-w","article-title":"Targeting macrophages: a novel treatment strategy in solid tumors","volume":"20","author":"Liu","year":"2022","journal-title":"J Transl Med"},{"issue":"10","key":"bib69","doi-asserted-by":"publisher","first-page":"BSR20221170","DOI":"10.1042\/BSR20221170","article-title":"Comprehensive analysis of DTYMK in pan-cancer and verification in lung adenocarcinoma","volume":"42","author":"Zhang","year":"2022","journal-title":"Biosci Rep"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1136\/ijgc-2023-004464","article-title":"PARP inhibitor era: current status and future directions","volume":"33","author":"Coleman","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"bib71","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00262-017-1991-1","article-title":"Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment","volume":"66","author":"Gezgin","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"bib25","article-title":"Drawing survival curves using \u201cggplot2\u201d:[R Package Survminer Version 0.4. 9]: Comprehensive R Archive Network (CRAN)","author":"Kassambara","year":"2021"},{"key":"bib56","article-title":"Conditional survival of patients with uveal melanoma - retina today"}],"container-title":["Investigative Ophthalmology &amp; Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2811019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:06Z","timestamp":1791927126000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2811019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":71,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.13.45","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,28]]}}}